BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 18823030)

  • 1. Second solid malignancies among children, adolescents, and young adults diagnosed with malignant bone tumors after 1976: follow-up of a Children's Oncology Group cohort.
    Goldsby R; Burke C; Nagarajan R; Zhou T; Chen Z; Marina N; Friedman D; Neglia J; Chuba P; Bhatia S
    Cancer; 2008 Nov; 113(9):2597-604. PubMed ID: 18823030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy.
    Teepen JC; van Leeuwen FE; Tissing WJ; van Dulmen-den Broeder E; van den Heuvel-Eibrink MM; van der Pal HJ; Loonen JJ; Bresters D; Versluys B; Neggers SJCMM; Jaspers MWM; Hauptmann M; van der Heiden-van der Loo M; Visser O; Kremer LCM; Ronckers CM;
    J Clin Oncol; 2017 Jul; 35(20):2288-2298. PubMed ID: 28530852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
    Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
    Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: the Italian Sarcoma Group Experience (1983-2006).
    Longhi A; Ferrari S; Tamburini A; Luksch R; Fagioli F; Bacci G; Ferrari C
    Cancer; 2012 Oct; 118(20):5050-9. PubMed ID: 22415578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults.
    Kube SJ; Blattmann C; Bielack SS; Kager L; Kaatsch P; Kühne T; Sorg B; Kevric M; Jabar S; Hallmen E; Sparber-Sauer M; Klingebiel T; Koscielniak E; Dirksen U; Hecker-Nolting S; Gerß JWO
    Cancer; 2022 May; 128(9):1787-1800. PubMed ID: 35195899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
    Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignant neoplasms in long-term survivors of osteosarcoma: Memorial Sloan-Kettering Cancer Center Experience.
    Aung L; Gorlick RG; Shi W; Thaler H; Shorter NA; Healey JH; Huvos AG; Meyers PA
    Cancer; 2002 Oct; 95(8):1728-34. PubMed ID: 12365021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
    Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary neoplasms after radiotherapy for a childhood solid tumor.
    Paulino AC; Fowler BZ
    Pediatr Hematol Oncol; 2005 Mar; 22(2):89-101. PubMed ID: 15804994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
    Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
    Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Marina NM; Liu Q; Donaldson SS; Sklar CA; Armstrong GT; Oeffinger KC; Leisenring WM; Ginsberg JP; Henderson TO; Neglia JP; Stovall MA; Yasui Y; Randall RL; Geller DS; Robison LL; Ness KK
    Cancer; 2017 Jul; 123(13):2551-2560. PubMed ID: 28222219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second cancer risk in childhood cancer survivors treated with intensity-modulated radiation therapy (IMRT).
    Casey DL; Friedman DN; Moskowitz CS; Hilden PD; Sklar CA; Wexler LH; Wolden SL
    Pediatr Blood Cancer; 2015 Feb; 62(2):311-316. PubMed ID: 25328040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary malignant neoplasms after osteosarcoma: early onset and cumulative alkylating agent dose dependency.
    Kim SH; Shin KH; Seok SO; Cho YJ; Noh JK; Suh JS; Yang WI
    Ann Surg Oncol; 2015 Mar; 22(3):859-65. PubMed ID: 25192682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.
    Friedman DN; Chastain K; Chou JF; Moskowitz CS; Adsuar R; Wexler LH; Chou AJ; DeRosa A; Candela J; Magnan H; Pun S; Kahan T; Wolden SL; Meyers PA; Oeffinger KC
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28417551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsequent malignant neoplasms in pediatric cancer patients treated with and without hematopoietic SCT.
    Pole JD; Darmawikarta D; Gassas A; Ali M; Egler M; Greenberg ML; Doyle J; Nathan PC; Schechter T
    Bone Marrow Transplant; 2015 May; 50(5):721-6. PubMed ID: 25706885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.